← FDA Drug Approvals (Drugs@FDA)

VIGABATRIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ALKEM LABS LTD · Approved 2020-12-02

Drug application

FDA Application #

ANDA213375

Application type

Abbreviated New Drug Application (Generic)

Brand name

VIGABATRIN

Generic name

VIGABATRIN

Active ingredients

VIGABATRIN

Dosage form

FOR SOLUTION

Route

ORAL

Marketing status

Prescription

Sponsor

ALKEM LABS LTD

Manufacturer

Ascend Laboratories, LLC

First approval

2020-12-02

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown